Dendritic cell/tumor hybrids enhances therapeutic efficacy against colorectal cancer liver metastasis in SCID mice

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 6, 2010, Pages 707-713

  Xu, Feng ^a   Ye, Ying Jiang ^a   Liu, Wei ^a   Kong, Meng ^a   He, Yu ^b   Wang, Shan ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Dendritic cell; Hybrid; Liver metastasis

Indexed keywords

DENDRITIC CELL VACCINE; GAMMA INTERFERON; MACROGOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER IMMUNIZATION; CANCER INHIBITION; CELL FUSION; CELL HYBRIDIZATION; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; LIVER HISTOLOGY; LIVER METASTASIS; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SCID MOUSE; SHAM PROCEDURE; THERAPY EFFECT;

ANIMALS; COLORECTAL NEOPLASMS; DENDRITIC CELLS; HUMANS; HYBRID CELLS; IMMUNITY, CELLULAR; LIVER NEOPLASMS; MALE; MICE; MICE, SCID; NEOPLASMS, EXPERIMENTAL; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; VACCINATION;

EID: 77952135173     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521003650180     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Cromheecke M, de Jong KP, Hoekstra HJ. Current treatment for colorectal cancer metastatic to the liver. Eur J Surg Oncol 1999;25:451-463
3. Steele G Jr, Ravikumar TS. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 1989;210:127-138
4. Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 2002;38:1023-1033
5. Gong J, Chen L, Chen D, Kashiwaba M, Manome Y, Tanaka T, et al. Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells. Gene Ther 1997;4:1023-1028 (Pubitemid 27469931)
6. Specht JM,Wang G,DoMT, Lam JS, Royal RE, Reeves ME, et al. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J Exp Med 1997;186:1213-1221
7. Rains N, Cannan RJ, Chen W, Stubbs RS. Development of a dendritic cell (DC)-based vaccine for patients with advanced colorectal cancer. Hepatogastroenterology 2001;48:347-351
8. Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD Jr. DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 1996;2:1122-1128
9. Song W, Kong HL, Carpenter H, Torii H, Granstein R, Rafii S, et al. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J Exp Med 1997;186:1247-1256
10. Ribas A, Butterfield LH, McBride WH, Jilani SM, Bui LA, Vollmer CM, et al. Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirustransducedmurinedendriticcells. CancerRes1997;57:2865-2869
11. Gong J, Chen D, Kashiwaba M, Kufe D. Induction of antitumor activity by with fusions of dendritic and carcinoma cells. Nat Med 1997;3:558-561 (Pubitemid 27198656)
12. Gong J, Avigan D, Chen D, Wu Z, Koido S, Kashiwaba M, et al. Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells. Proc Natl Acad Sci USA 2000;97:2715-2718 (Pubitemid 30159237)
13. Wang J, Saffold S, Cao X, Krauss J, Chen W. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. J Immunol 1998;161:5516-5524 (Pubitemid 28519115)
14. Chen D, Xia J, Tanaka Y, Chen H, Koido S, Wernet O, et al. Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells. Immunology 2003;109:300-307
15. Kawada M, Ikeda H, Takahashi T, Ishizu A, Ishikura H, Katoh H, et al. Vaccination of fusion cells of rat dendritic and carcinoma cells prevents tumor growth in vivo. Int J Cancer 2003;105:520-526
16. Avigan D, Vasir B, Gong J, Borges V, Wu Z, Uhl L, et al. Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses. Clin Cancer Res 2004;10: 4699-4708
17. Raje N, Hideshima T, Davies FE, Chauhan D, Treon SP, Young G, et al. Tumor cell/dendritic cell fusion as a vaccination strategy for multiple myeloma. Br J Haematol 2004;125:343-352
18. Xu F, Ye YJ, Cui ZR, Wang S. Allogeneic dendritomas induce anti-tumour immunity against metastatic colon cancer. Scand J Immunol 2005;61:364-369
19. Kuruppu D, Christophi C, Bertram JF, O'Brien PE. Characterization of an animal model of hepatic metastasis. J Gastroenterol Hepatol 1996;11:26-32.
20. Xu F, Ye YJ, Wang S. In vitro antitumor immune response induced by fusion of dendritic cells and colon cancer cells. World J Gastroenterol 2004;10:1162-1166
21. Jäger E, Gnjatic S, Nagata Y, Stockert E, Jäger D, Karbach J, et al. Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc Natl Acad Sci USA 2000;97:12198-12203
22. Atkins D, Breuckmann A, Schmahl GE, Binner P, Ferrone S, Krummenauer F, et al. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma. Int J Cancer 2004;109:265-273
23. Araibi EH, Marchetti B, Ashrafi GH, Campo MS. Downregulation of major histocompatibility complex class I in bovine papillomas. J Gen Virol 2004;85(Pt 10): 2809-2814
24. Muris JJ, Meijer CJ, Cillessen SA, Vos W, Kummer JA, Bladergroen BA, et al. Prognostic significance of activated cytotoxic T lymphocytes in primary nodal diffuse large B-cell lymphomas. Leukemia 2004;18:589-596
25. Shu S, Cohen P. Tumor-dendritic cell fusion technology and immunotherapy strategies. J immunother 2001;24:99-100.
26. Hsueh EC, Nathanson L, Foshag LJ, Essner R, Nizze JA, Stern SL, et al. Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in-transit melanoma metastases. Cancer 1999;85:2160-2169
27. Chan RC, Xie H, Zhao GP, Xie Y. Dendritomas formed by fusion of mature dendritic cells with allogenic human hepatocellular carcinoma cells activate autologous cytotoxic T lymphocytes. Immunol Lett 2002;83:101-109
28. Trevor KT, Cover C, Ruiz YW, Akporiaye ET, Hersh EM, Landais D, et al. Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application. Cancer Immunol Immunother 2004;53:705-714
29. Gong J, Nikrui N, Chen D, Koido S, Wu Z, Tanaka Y, et al. Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity. J Immunol 2000;165:1705-1711 (Pubitemid 30604610)
30. Fifis T, Lam I, Lin D, Malcontenti-Wilson C, Christophi C, Loveland B. Vaccination with in vitro grown whole tumor cells induces strong immune responses and retards tumor growth in a murine model of colorectal liver metastases. Vaccine 2008;26:241-249
31. Ohtani H. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun 2007;7:4.
32. Srivastava PK, Deleo AB, Old LJ. Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc Natl Acad Sci USA 1986;83:3407-3411